Developments of diagnostics for Mild Cognitive Impairment by patients serum and inhibition of the disease progress with vitamin D
Developments of diagnostics for Mild Cognitive Impairment by patients serum and inhibition of the disease progress with vitamin D
批准号:
23590697
负责人:
MATSUNAGA Yoichi
金额:
$3.41万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013
中文摘要
聚集的淀粉样蛋白-β是阿尔茨海默病(AD)的病理特征,轻度认知障碍(MCI)是AD的早期阶段。迄今为止,还没有通过患者血清诊断MCI的方法。MCI患者血清25(OH)V-D_3浓度低于正常人,而1,25(OH)_2 V-D_3浓度与正常人无显著性差异。提示血清25(OH)V-D_3浓度对MCI的诊断有一定的参考价值。25(OH)V-D3在体外对聚集没有抑制作用,反而促进了聚集。PrPsc是引起羊瘙痒病的主要蛋白质,它来源于PrPc在正常脑内的构象转变。PrPc的低聚是PrPsc的前阶段。我们发现VD 3不能破坏寡聚化,而VD 2可以破坏寡聚化,这表明VD 2可用于瘙痒症的治疗。
英文摘要
Aggregated amyloid-beta is a pathological feature in Alzheimer's disease(AD) and mild cognitive impairment(MCI) is an early stage of AD. Up to date, there is no diagnostics of MCI by patients serum. We found that the concentration of 25(OH)V-D3 in serum with MCI is lower than that of normal volunteers, and there is no differences in the concentration of 1,25(OH)2V-D3 between them. We suggest that the serum concentration of 25(OH)V-D3 is useful for the diagnostics of MCI. Unexpectedly, 25(OH)V-D3 showed no inhibitory effects for the aggregation in vitro, and rather promoted the aggregation.PrPsc is the responsible protein to cause scrapie, which derived from the conformational transition of PrPc in normal brain. Oligomerization of PrPc is a pre-stage of PrPsc. We found that V-D3 could not break the oligomerization, however VD2 could break the oligzation, suggesting that VD2 is useful for scrapie therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Refractory acute disseminated encephalomyelitis with anti-galactocerebroside antibody
抗半乳脑苷脂抗体难治性急性播散性脑脊髓炎
DOI:
--
发表时间:
2012
期刊:
Neurosci. Res
影响因子:
--
作者:
[Samukawa M, Hirano M, Tsugawa J, Sakamoto H, Tabata E, Takada K, Kuwahara M, Suzuki S, Kitada M, Yamada T, Hara H, Tsuboi Y, Nakamura Y, Kusunoki S]
通讯作者:
Kusunoki S
Environmental factors preceding A-beta40 monomer to oligomers and the function of patients with Parkinson's disease patient serum
A-β40单体向寡聚体转变的环境因素及帕金森病患者血清的功能
DOI:
--
发表时间:
2012
期刊:
J. Amino Acids
影响因子:
--
作者:
[Matsunaga Y, Suenaga M]
通讯作者:
Suenaga M
ヒト単球由来ApoE分解酵素の探索
寻找源自人单核细胞的 ApoE 降解酶
DOI:
--
发表时间:
2012
期刊:
影响因子:
--
作者:
[末永みどり, 西原利治, 松永洋一]
通讯作者:
松永洋一
DOI:
10.1248/cpb.c13-00006
发表时间:
2013-04
期刊:
Chemical & pharmaceutical bulletin
影响因子:
1.7
作者:
[Hirofumi Yamamoto;M. Oda;Mayo Nakano;Kenta Yabiku;M. Shibutani;Toshiyuki Nakanishi;Midori Suenaga;Masahisa Inoue;H. Imagawa;M. Nagahama;Y. Matsunaga;S. Himeno;K. Setsu;J. Sakùrai;M. Nishizawa*]
通讯作者:
Hirofumi Yamamoto;M. Oda;Mayo Nakano;Kenta Yabiku;M. Shibutani;Toshiyuki Nakanishi;Midori Suenaga;Masahisa Inoue;H. Imagawa;M. Nagahama;Y. Matsunaga;S. Himeno;K. Setsu;J. Sakùrai;M. Nishizawa*
Effects of 8-residue beta-sheet breaker peptides on aged A-beta40 induced memory impariment and A-beta40 expression in rat brain and serum fpllowing intraamygdaloid injection
8 残基 β-折叠肽对老年 A-β40 诱导的记忆障碍以及杏仁内注射后大鼠脑和血清中 A-β40 表达的影响
DOI:
--
发表时间:
2010
期刊:
Curr. Alz. Res
影响因子:
--
作者:
[Hatip FB, Hatip KA, Matsunaga Y, Suenaga M, Sen N]
通讯作者:
Sen N
共 18 条
Serum vitamin D concentration is a biomarker for early stage of Alzheimer's disease and control amyliod-beta aggregation.
-
批准号:15K08631
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2015
-
负责人:MATSUNAGA Yoichi
-
依托单位:
A new diagnostic approach of Alzheimer's Disease based on the conformational changes of Aβ in serum
-
批准号:20590592
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2008
-
负责人:MATSUNAGA Yoichi
-
依托单位:
A role of spleen in the conformational transition of prion protein
-
批准号:16590857
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.16万
-
财政年份:2004
-
负责人:MATSUNAGA Yoichi
-
依托单位: